BackgroundCheck.run
Search For

Sandeep B Dutta, 60190 Shooting Star Isle, San Mateo, CA 94404

Related to:
Malini Dutta 59 Nikhil Dutta 28

Sandeep Dutta Phones & Addresses

190 Shooting Star Isle, Foster City, CA 94404    650-2861888   

1131 Compass Ln, Foster City, CA 94404    650-2861888    650-5715160   

3331 Verdun Ave, San Mateo, CA 94403    650-2861888   

Oak Park, IL   

Chicago, IL   

Naperville, IL   

Kingston, NY   

Get Report
Control this profile

Mentions for Sandeep B Dutta

Sandeep Dutta resumes & CV records

Resumes

Sandeep Dutta Photo 27

Partner At Mckinsey & Company

Position:
Partner at McKinsey & Company
Location:
United States
Industry:
Computer Software
Work:
McKinsey & Company
Partner
Education:
Massachusetts Institute of Technology 2001 - 2003
Sandeep Dutta Photo 28

Sandeep Dutta

Location:
San Francisco, CA
Industry:
Semiconductors
Skills:
Verilog, C++, Processors, Compiler Construction, C, Embedded Software, Fpga, Vhdl, Microprocessors, Soc, Arm, Asic, Semiconductors, Eda, Device Drivers, Debugging, High Performance Computing, Perl, Embedded Systems, Digital Signal Processors, Low Power Design
Sandeep Dutta Photo 29

Processor Architect

Location:
San Francisco, CA
Industry:
Semiconductors
Work:
Lattice Semiconductor
Processor Architect
Sandeep Dutta Photo 30

Online Marketing Manager

Work:

Online Marketing Manager
Sandeep Dutta Photo 31

Sandeep Dutta

Publications & IP owners

Us Patents

Controlled Release Formulation Of Divalproex Sodium

US Patent:
6511678, Jan 28, 2003
Filed:
Dec 22, 2000
Appl. No.:
09/748567
Inventors:
Yihong Qiu - Gumee IL
J. Daniel Bollinger - Libertyville IL
Sandeep Dutta - Waukegan IL
Howard S. Cheskin - Glencoe IL
Kevin R. Engh - Kenosha WI
Richard P. Poska - Mundelein IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 900
US Classification:
424464, 442465, 442489, 442499, 442468, 442470
Abstract:
A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have been achieved. This results in a significantly lower incidence of side effects for patients consuming such a formulation.

Controlled Release Formulation Of Divalproex Sodium

US Patent:
6528090, Mar 4, 2003
Filed:
Dec 22, 2000
Appl. No.:
09/748566
Inventors:
Yihong Qiu - Gumee IL
J. Daniel Bollinger - Libertyville IL
Howard S. Cheskin - Glencoe IL
Sandeep Dutta - Waukegan IL
Kevin R. Engh - Kenosha WI
Richard P. Poska - Mundelein IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 900
US Classification:
424464, 424465, 424489, 424499, 424468, 424470
Abstract:
A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have been achieved. This results in a significantly lower incidence of side effects for patients consuming such a formulation.

Controlled Release Formulation Of Divalproex Sodium

US Patent:
6713086, Mar 30, 2004
Filed:
Aug 8, 2002
Appl. No.:
10/215142
Inventors:
Yihong Qiu - Gumee IL
J. Daniel Bollinger - Libertyville IL
Howard S. Cheskin - Glencoe IL
Sandeep Dutta - Waukegan IL
Kevin R. Engh - Kenosha IL
Richard P. Poska - Mundelein IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 900
US Classification:
424464, 424465, 424468, 424470, 424489, 424499
Abstract:
A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have been achieved. This results in a significantly lower incidence of side effects for patients consuming such a formulation.

Controlled Release Formulation Of Divalproex Sodium

US Patent:
6720004, Apr 13, 2004
Filed:
Aug 8, 2002
Appl. No.:
10/215141
Inventors:
Yihong Qiu - Gumee IL
J. Daniel Bollinger - Libertyville IL
Sandeep Dutta - Waukegan IL
Howard S. Cheskin - Glencoe IL
Kevin R. Engh - Kenosha WI
Richard P. Poska - Mundelein IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 900
US Classification:
424464, 424465, 424468, 424470, 424489, 424499
Abstract:
A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have been achieved. This results in a significantly lower incidence of side effects for patients consuming such a formulation.

System And Method For Memory Reclamation

US Patent:
6874074, Mar 29, 2005
Filed:
Nov 13, 2000
Appl. No.:
09/711589
Inventors:
Felix Burton - San Mateo CA, US
Sandeep Dutta - Foster City CA, US
Assignee:
Wind River Systems, Inc. - Alameda CA
International Classification:
G06F012/16
G06F012/02
US Classification:
711170, 711158, 707206, 717140
Abstract:
A method for memory reclamation is disclosed that includes marking a memory object when an attempt to alter a reference to the memory object is detected by a software write barrier. Marking be by using representations (“black,” “white”, “gray”) stored as part of a garbage collection information data structure associated with each memory object. Initially, all allocated memory objects are marked white. Objects are then processed such that objects referenced by pointers are marked gray. Each object marked gray is then processed to determine objects referenced by pointers in it, and such objects are marked gray. When all objects referenced by pointers in the selected gray objected have been processed, the selected gray object is marked black. When all processing has been completed, objects still marked white may be reclaimed. Also described is a garbage collector which runs as a task concurrently with other tasks.

System And Method For Transformation Of Assembly Code For Conditional Execution

US Patent:
7120905, Oct 10, 2006
Filed:
Jan 29, 2003
Appl. No.:
10/354898
Inventors:
Sandeep Dutta - Foster City CA, US
Paul Beusterien - Alameda CA, US
Tomas Evensen - Foster City CA, US
Assignee:
Wind River Systems, Inc. - Alameda CA
International Classification:
G06F 9/45
US Classification:
717156
Abstract:
A method and system may be implemented, according to a preferred embodiment of the present invention, to permit transformation of software to use conditional execution instructions. According to the preferred embodiment, a system and method is provided to transform machine instructions (for example, machine instructions generated by a source code compiler) to make use of the conditional execution features of a processor. The preferred embodiment thus reduces code size and better utilizes the instruction pipeline and cache.

Treatment Of Attention-Deficit/Hyperactivity Disorder

US Patent:
8222278, Jul 17, 2012
Filed:
May 29, 2009
Appl. No.:
12/475440
Inventors:
Earle E. Bain - Libertyville IL, US
Walid M. Abi-Saab - Dornach, CH
Sandeep Dutta - Gurnee IL, US
Tushar S. Garimella - Skokie IL, US
Walid M. Awni - Libertyville IL, US
Mario D. Saltarelli - Lake Bluff IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/44
US Classification:
514338
Abstract:
3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3. 2. 0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.

Controlled Release Formulation Of Divalproex Sodium

US Patent:
2002002, Feb 28, 2002
Filed:
Jun 8, 2001
Appl. No.:
09/877682
Inventors:
Yihong Qiu - Gumee IL, US
J. Bollinger - Libertyville IL, US
Sandeep Dutta - Waukegan IL, US
Howard Cheskin - Glencoe IL, US
Kevin Engh - Kenosha WI, US
Richard Poska - Mundelein IL, US
Kenneth Sommerville - Libertyville IL, US
International Classification:
A61K009/22
US Classification:
424/489000, 424/468000
Abstract:
A new oral polymeric controlled release formulation suitable for the once-a-day administration of valproate compounds, such as divalproex sodium, has been discovered. This formulation exhibits significant advantages over the sustained release valproate formulations of the prior art. This formulation minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have been achieved. This results in a significantly lower incidence of side effects for patients consuming such a formulation.

Possible Relatives

Dipak K Dutta  Abhijit Dutta  Abhik K Dutta  Indira B Dutta  Jennifer Dutta  Jyoti P Dutta  Kamal K Dutta  Sandeep N Nair  Sandeep Singh  Sandeep M Patel 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.